Curcumin, a traditional spice component, can hold the promise against COVID-19?

VK Soni, A Mehta, YK Ratre, AK Tiwari, A Amit… - European Journal of …, 2020 - Elsevier
The severity of the recent pandemic and the absence of any specific medication impelled the
identification of existing drugs with potential in the treatment of Coronavirus disease-2019 …

Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial

N Saber‐Moghaddam, S Salari, S Hejazi… - Phytotherapy …, 2021 - Wiley Online Library
Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …

Natural products as home‐based prophylactic and symptom management agents in the setting of COVID‐19

SM Thota, V Balan… - Phytotherapy …, 2020 - Wiley Online Library
Coronavirus disease (COVID‐19) caused by the novel coronavirus (SARS‐CoV‐2) has
rapidly spread across the globe affecting 213 countries or territories with greater than six …

A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and …

M Hassaniazad, E Eftekhar… - Phytotherapy …, 2021 - Wiley Online Library
In COVID‐19 patients, cytokine storm due to excessive immune responses can cause
severe complications. In this study, we investigated the effect of curcumin nanomicelles on …

[HTML][HTML] The inhibitory effect of curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia

Z Liu, Y Ying - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Coronavirus infection, including SARS-CoV, MERS-CoV, and SARS-CoV2, causes daunting
diseases that can be fatal because of lung failure and systemic cytokine storm. The …

Curcumin use in pulmonary diseases: State of the art and future perspectives

D Lelli, A Sahebkar, TP Johnston, C Pedone - Pharmacological research, 2017 - Elsevier
Curcumin (diferuloylmethane) is a yellow pigment present in the spice turmeric (Curcuma
longa). It has been used for centuries in Ayurveda (Indian traditional medicine) for the …

Practical murine hematopathology: a comparative review and implications for research

KE O'Connell, AM Mikkola, AM Stepanek… - Comparative …, 2015 - ingentaconnect.com
Hematologic parameters are important markers of disease in human and veterinary
medicine. Biomedical research has benefited from mouse models that recapitulate such …

[HTML][HTML] Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases

M Sadeghi, S Dehnavi, A Asadirad, S Xu… - …, 2023 - Springer
Chemokines belong to the family of cytokines with chemoattractant properties that regulate
chemotaxis and leukocyte migration, as well as the induction of angiogenesis and …

Curcumin: An effective inhibitor of interleukin-6

M Ghandadi, A Sahebkar - Current pharmaceutical design, 2017 - ingentaconnect.com
Curcumin is apolyphenolic cominflammatory effects of curcumin. Moreover, curcumin can be
considered as potential therapy against IL-6 involvepound found in the dietary spice …

Food policy, nutrition and nutraceuticals in the prevention and management of COVID-19: Advice for healthcare professionals

YI Ayseli, N Aytekin, D Buyukkayhan, I Aslan… - Trends in Food Science …, 2020 - Elsevier
Abstract Background The 2019 novel coronavirus (2019-nCoV) represents an ongoing
major global health crisis with a potentially unprecedented death toll and socio-economic …